<code id='0D306BB2EA'></code><style id='0D306BB2EA'></style>
      • <acronym id='0D306BB2EA'></acronym>
      <center id='0D306BB2EA'><center id='0D306BB2EA'><tfoot id='0D306BB2EA'></tfoot></center><abbr id='0D306BB2EA'><dir id='0D306BB2EA'><tfoot id='0D306BB2EA'></tfoot><noframes id='0D306BB2EA'>
      • <optgroup id='0D306BB2EA'><strike id='0D306BB2EA'><sup id='0D306BB2EA'></sup></strike><code id='0D306BB2EA'></code></optgroup>
        5. <b id='0D306BB2EA'><label id='0D306BB2EA'><select id='0D306BB2EA'><dt id='0D306BB2EA'><span id='0D306BB2EA'></span></dt></select></label></b><u id='0D306BB2EA'></u>
          <i id='0D306BB2EA'><strike id='0D306BB2EA'><tt id='0D306BB2EA'><pre id='0D306BB2EA'></pre></tt></strike></i>
          
    
          
      
          
       
      
          
        
      
          
      
          
        
          
          
          
            
          
            
          
              
          
                
          leisure time 
          
                
          
                
          
              
          
            
          
            
            
          
          
          
       
        
          
      
          
      
          
        
          
        
          
          
            
          
                           
          leisure time  
          
                                   
                 
                                      author：knowledge   
                                        
                                      
                                      Page View：261
                                  
                                    
          
                                    
          Alexis Borisy
          Venture capitalist Alexis Borisy																									Vanessa Leroy for STAT
          EQRx is done, sold for its cash.
          The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.
          advertisement
          The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.
          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!					
          GET STARTED													Log In											
                      
                              
          
                                 Previous article：

                                
                                          1 in 4 Americans hadn't contracted COVID by the end of 2022, CDC estimates
                                
                            
          Next article：  
                                      
                                          State Dept. review finds Biden bears some blame for Afghanistan failures
                                                                    
          
            
          
           
            
          
          
          
       
          
        
          
        
      
          
      
          
                                                
        
          explore
          
                  
          

                    
          
            
          
              
                Guidelines to prevent youth baseball injuries need more muscle
                
          
                        
              
          
                Guidelines to prevent youth baseball injuries need more muscle
                
          
                  
          Apitcheratthe2018LittleLeagueWorldSeries.RobCarr/GettyImages“Weallknowthatweareinthemiddleofanepidem
          
                
          
                
                  read more
                    
                  
              
          
            
          
          
          
                   
          
            
          
              
                2 million sign
                
          
                        
              
          
                2 million sign
                
          
                  
          2:55MarkZuckerberg,chiefexecutiveofficerandfounderofFacebookInc.,speaksduringtheSiliconSlopesTechSum
          
                
          
                
                  read more
                    
                  
              
          
            
          
          
          
                   
          
            
          
              
                Duchenne breakthrough therapy leaves behind pioneering families
                
          
                        
              
          
                Duchenne breakthrough therapy leaves behind pioneering families
                
          
                  
          DuchennemusculardystrophyDr.EdwinP.Ewing,Jr./CDCPatFurlongwassittinginherhomeofficeinMiddletown,Ohio
          
                
          
                
                  read more
                    
                  
              
          
            
          
          
          
         
        
          
          
        
          

          
          
            
          
          
          
            
          Pregnant women don't need prenatal multivitamins, study concludes
          
            
          APStockPrenatalvitaminsareastapleofmodernpregnancy. ButareportoutMondayin thejournalDrugandTherapeut
          
          
          
          
          
            read more